COMPASS: Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low-dose rivaroxaban, or the combination: Secondary analysis of the randomised controlled trial
Alimentary Pharmacology & Therapeutics
Forbes N, Yi Q, Moayyedi P, Bosch J, Bhatt DL, Fox KAA, Eikelboom JW.
July 2024